Se-Mi Kim
Chonnam National University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Se-Mi Kim.
Biomedical Chromatography | 2009
Hye Won Lee; Hye Young Ji; Dong Hwan Sohn; Se-Mi Kim; Yong-Bok Lee; Hye Suk Lee
A rapid, sensitive and selective liquid chromatography-electrospray ionization mass spectrometric method for the determination of loxoprofen in human plasma was developed. Loxoprofen and ketoprofen (internal standard) were extracted from 20 microL of human plasma sample using ethyl acetate at acidic pH and analyzed on an Atlantis dC(18) column with the mobile phase of methanol:water (75:25, v/v). The analytes were quantified in the selected reaction monitoring mode. The standard curve was linear over the concentration range of 0.1-20 microg/mL with a lower limit of quantification of 0.1 microg/mL. The coefficient of variation and relative error for intra- and inter-assay at four quality control levels were 2.8-5.2 and 4.8-7.0%, respectively. The recoveries of loxoprofen and ketoprofen were 69.7 and 67.6%, respectively. The matrix effects for loxoprofen and ketoprofen were practically absent. This method was successfully applied to the pharmacokinetic study of loxoprofen in humans.
Journal of Pharmaceutical Investigation | 2010
Hyun-Ah Kang; Se-Mi Kim; Seung-Rae Kang; Min-Sun Kang; Sang-No Lee; In-Ho Kwon; Hee-Doo Yoo; Yoon Gyoon Kim; Yong-Bok Lee
【The purpose of the present study was to evaluate the bioequivalence of two choline alphoscerate soft capsules, Gliatilin soft capsule (Daewoong Pharmaceuticals Co., Ltd.) and Cholicerin soft capsule (Sam Chun Dang Pharm. Co., Ltd.), according to the guidelines of Korea Food and Drug Administration (KFDA). Serum concentrations of choline after oral administration of choline alphoscerate were determined using a validated LC/MS/MS method. This method showed linear response over the concentration range of 0.5-20
Journal of Pharmaceutical Investigation | 2005
Hea-Young Cho; Hyun-Ah Kang; Chan-Ho Park; Se-Mi Kim; Dong-Ho Kim; Sun-Ae Park; Kyung-Ran Kim; Hyeon Hur; Yong-Bok Lee
{\mu}g
Journal of Pharmaceutical Investigation | 2005
Hea-Young Cho; Eun-Ja Park; Hyun-Ah Kang; Se-Mi Kim; Chan-Ho Park; In-Joon Oh; Dong-Koo Lim; Myung-Hee Lee; Yong-Bok Lee
/mL with correlation coefficient of 0.9999. The lower limit of quantitation using 100
Journal of Pharmaceutical Investigation | 2010
Hyun-Ah Kang; Se-Mi Kim; Min-Sun Kang; Dong-Jin Yoo; Sang-No Lee; In-Ho Kwon; Hee-Doo Yoo; Yong-Bok Lee
{\mu}L
Journal of Korean Pharmaceutical Sciences | 2010
Hyun-Ah Kang; Se-Mi Kim; Dong-Jin Yoo; Seung-Rae Kang; Sang-No Lee; Yong-Hee Kim; Yong-Bok Lee
of serum was 0.5
Journal of Korean Pharmaceutical Sciences | 2009
Se-Mi Kim; Sang-No Lee; Hwa Yoon; Hyun-Ah Kang; Hea-Young Cho; Il-Kwon Lee; Yong-Bok Lee
{\mu}g
Journal of Pharmaceutical Investigation | 2008
Se-Mi Kim; Sun-Ae Park; Hea-Young Cho; Yong-Bok Lee
/mL which was sensitive enough for pharmacokinetic studies. Thirty six healthy male Korean volunteers received each medicine at the choline alphoscerate dose of 1200 mg in a
Journal of Pharmaceutical Investigation | 2008
Jong-Seob Im; Dong-Hoon Oh; Dong-Xun Li; Jung-Hoon Sung; Bong-Kyu Yoo; Jung-Ae Kim; Jong-Soo Woo; Yong-Bok Lee; Se-Mi Kim; Han-Gon Choi; Chul-Soon Yong
2{\times}2
Journal of Pharmaceutical Investigation | 2008
Se-Mi Kim; Hwa Yoon; Hee-Doo Yoo; Kyung-Ran Kim; Hyun-Ah Kang; Hea-Young Cho; Yong-Bok Lee
crossover study. There was a one-week washout period between the doses. Blood samples were taken at predetermined time intervals up to 8 hr.